Cargando…
Impact of sex and age on vaccine-related side effects and their progression after booster mRNA COVID-19 vaccine
In mRNA COVID-19 vaccination, side effects after the first and second dose have been well reported. However, studies about side effects after booster vaccine are sparse. 272 healthcare workers who received the third mRNA COVID-19 vaccine were recruited, and impact of sex, age, and symptoms on the si...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630308/ https://www.ncbi.nlm.nih.gov/pubmed/37935801 http://dx.doi.org/10.1038/s41598-023-46823-4 |
_version_ | 1785132122588053504 |
---|---|
author | Mori, Masahiko Yokoyama, Aiko Shichida, Ayami Sasuga, Kimiko Maekawa, Takafumi Moriyama, Tadayoshi |
author_facet | Mori, Masahiko Yokoyama, Aiko Shichida, Ayami Sasuga, Kimiko Maekawa, Takafumi Moriyama, Tadayoshi |
author_sort | Mori, Masahiko |
collection | PubMed |
description | In mRNA COVID-19 vaccination, side effects after the first and second dose have been well reported. However, studies about side effects after booster vaccine are sparse. 272 healthcare workers who received the third mRNA COVID-19 vaccine were recruited, and impact of sex, age, and symptoms on the side effect progression was statistically analyzed. Females and younger adults had a higher frequencies of general fatigue, headache, joint pain, chills and axillary pain compared to males and elderly adults, respectively. In longitudinal analysis, prolonged time to recovery from side effects was found among females and younger adults. Finally, between the third and second dose vaccinations, 52% of subjects had a longer duration of side effects following the third vaccine compared to the second, and joint pain was the culprit symptom related to the prolonged duration of side effects. Following the second vaccine dose, 25% of subjects had a longer duration of side effects and asthma and ear fullness, which exacerbated the underlying allergic condition, and COVID arm symptom were the culprit symptoms. These highlight the impact of sex, age, and culprit symptoms on the progress of side effects following the booster mRNA COVID-19 vaccine. |
format | Online Article Text |
id | pubmed-10630308 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-106303082023-11-07 Impact of sex and age on vaccine-related side effects and their progression after booster mRNA COVID-19 vaccine Mori, Masahiko Yokoyama, Aiko Shichida, Ayami Sasuga, Kimiko Maekawa, Takafumi Moriyama, Tadayoshi Sci Rep Article In mRNA COVID-19 vaccination, side effects after the first and second dose have been well reported. However, studies about side effects after booster vaccine are sparse. 272 healthcare workers who received the third mRNA COVID-19 vaccine were recruited, and impact of sex, age, and symptoms on the side effect progression was statistically analyzed. Females and younger adults had a higher frequencies of general fatigue, headache, joint pain, chills and axillary pain compared to males and elderly adults, respectively. In longitudinal analysis, prolonged time to recovery from side effects was found among females and younger adults. Finally, between the third and second dose vaccinations, 52% of subjects had a longer duration of side effects following the third vaccine compared to the second, and joint pain was the culprit symptom related to the prolonged duration of side effects. Following the second vaccine dose, 25% of subjects had a longer duration of side effects and asthma and ear fullness, which exacerbated the underlying allergic condition, and COVID arm symptom were the culprit symptoms. These highlight the impact of sex, age, and culprit symptoms on the progress of side effects following the booster mRNA COVID-19 vaccine. Nature Publishing Group UK 2023-11-07 /pmc/articles/PMC10630308/ /pubmed/37935801 http://dx.doi.org/10.1038/s41598-023-46823-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Mori, Masahiko Yokoyama, Aiko Shichida, Ayami Sasuga, Kimiko Maekawa, Takafumi Moriyama, Tadayoshi Impact of sex and age on vaccine-related side effects and their progression after booster mRNA COVID-19 vaccine |
title | Impact of sex and age on vaccine-related side effects and their progression after booster mRNA COVID-19 vaccine |
title_full | Impact of sex and age on vaccine-related side effects and their progression after booster mRNA COVID-19 vaccine |
title_fullStr | Impact of sex and age on vaccine-related side effects and their progression after booster mRNA COVID-19 vaccine |
title_full_unstemmed | Impact of sex and age on vaccine-related side effects and their progression after booster mRNA COVID-19 vaccine |
title_short | Impact of sex and age on vaccine-related side effects and their progression after booster mRNA COVID-19 vaccine |
title_sort | impact of sex and age on vaccine-related side effects and their progression after booster mrna covid-19 vaccine |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630308/ https://www.ncbi.nlm.nih.gov/pubmed/37935801 http://dx.doi.org/10.1038/s41598-023-46823-4 |
work_keys_str_mv | AT morimasahiko impactofsexandageonvaccinerelatedsideeffectsandtheirprogressionafterboostermrnacovid19vaccine AT yokoyamaaiko impactofsexandageonvaccinerelatedsideeffectsandtheirprogressionafterboostermrnacovid19vaccine AT shichidaayami impactofsexandageonvaccinerelatedsideeffectsandtheirprogressionafterboostermrnacovid19vaccine AT sasugakimiko impactofsexandageonvaccinerelatedsideeffectsandtheirprogressionafterboostermrnacovid19vaccine AT maekawatakafumi impactofsexandageonvaccinerelatedsideeffectsandtheirprogressionafterboostermrnacovid19vaccine AT moriyamatadayoshi impactofsexandageonvaccinerelatedsideeffectsandtheirprogressionafterboostermrnacovid19vaccine |